PBMC-based Leukocyte Immunotherapy

Clinical trial NCT06172894 · COMPLETED

Trial details

NCT number: NCT06172894
Sponsor: invIOs GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-08-22
Primary completion: 2024-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.